Your browser doesn't support javascript.
loading
[Myelodysplastic syndrome with CREST syndrome successfully treated with metenolone--A case report].
Hamamoto, K; Ohno, T; Ogawa, H.
  • Hamamoto K; Third Department of Internal Medicine, Japanese Red Cross Society Wakayama Medical Center, Japan.
Rinsho Ketsueki ; 37(4): 362-5, 1996 Apr.
Article en Ja | MEDLINE | ID: mdl-8847810
ABSTRACT
A 54-year-old woman was diagnosed as having refractory anemia (RA) with CREST syndrome (incomplete type). She showed Raynaud's phenomenon, sclerodactyly and telangiectasia, but not calcinosis and esophageal dysmotility. Laboratory findings revealed anemia and thrombocytopenia, and myelodysplasia, abnormal karyotype of 47, XX, +8 in bone marrow cells. Antinuclear and centromere antibody was positive. Treatment with prednisolone was not successful. After prednisolone was tapered, she was given 20 mg/body metenolone orally, which led to hematological improvement, and after 6 months of therapy, abnormal karyotype of 47, XX, +8 disappeared.
Asunto(s)
Search on Google
Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Síndrome CREST / Anabolizantes / Metenolona Límite: Female / Humans / Middle aged Idioma: Ja Año: 1996 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Síndrome CREST / Anabolizantes / Metenolona Límite: Female / Humans / Middle aged Idioma: Ja Año: 1996 Tipo del documento: Article